Healthcare - Biotechnology - NASDAQ - US
$ 2.9
-8.8 %
$ 5.02 M
Market Cap
-0.64
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
94.47%
Net Income
Estimate
--3595.63%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Exicure, Inc.
XCUR has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart XCUR
EBIT FORECAST
EBIT Forecast Chart XCUR
NET INCOME FORECAST
Net Income Chart XCUR